会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Modulation of biological signal transduction by RNA interference
    • 通过RNA干扰调节生物信号转导
    • US07399586B2
    • 2008-07-15
    • US10444795
    • 2003-05-23
    • Richard KlinghofferStephen Patrick Lewis
    • Richard KlinghofferStephen Patrick Lewis
    • C12Q1/68C12P19/34C12N15/03C12N15/00C07N21/04
    • C12N15/1137A61K38/00C12N2310/111C12N2310/14C12N2310/3517C12N2310/53C12Y301/03048
    • Compositions and methods relating to small interfering RNA (siRNA) polynucleotides are provided as pertains to modulation of biological signal transduction. Shown are siRNA polynucleotides that interfere with expression of members of the protein tyrosine phosphatase (PTP) class of enzymes that mediate signal transduction, and with certain MAP kinase kinases (MKK). In certain preferred embodiments siRNA modulate signal transduction pathways comprising SHP2, cdc14a/b, cdc25A/B/C, KAP, PTP-ε, PRL-3, CD45, dual specificity phosphatase-3 (DSP-3), MKK-4, and/or MKK-7. Modulation of PTP-mediated biological signal transduction has uses in diseases associated with defects in cell proliferation, cell differentiation and/or cell survival, such as metabolic disorders (including diabetes and obesity), cancer, autoimmune disease, infectious and inflammatory disorders and other conditions. The invention also provides siRNA polynucleotides that interfere with expression of chemotherapeutic target polypeptides, such as DHFR, thymidylate synthetase, and topoisomerase I.
    • 提供了与小干扰RNA(siRNA)多核苷酸相关的组合物和方法,涉及生物信号转导的调节。 显示干扰介导信号转导的酶的蛋白酪氨酸磷酸酶(PTP)类成员和某些MAP激酶激酶(MKK)的成员的表达的siRNA多核苷酸。 在某些优选实施方案中,siRNA调节包含SHP2,cdc14a / b,cdc25A / B / C,KAP,PTP-ε,PRL-3,CD45,双特异性磷酸酶-3(DSP-3),MKK-4和 /或MKK-7。 PTP介导的生物信号转导的调节在与细胞增殖,细胞分化和/或细胞存活缺陷相关的疾病中使用,例如代谢紊乱(包括糖尿病和肥胖症),癌症,自身免疫性疾病,感染性和炎症性疾病和其他病症 。 本发明还提供干扰化学治疗靶多肽如DHFR,胸苷酸合成酶和拓扑异构酶I的表达的siRNA多核苷酸。
    • 9. 发明申请
    • Reversible oxidation of protein tyrosine phosphatases
    • 蛋白酪氨酸磷酸酶的可逆氧化
    • US20030215899A1
    • 2003-11-20
    • US10366547
    • 2003-02-12
    • CEPTYR, Inc.Cold Spring Harbor Laboratory
    • Tzu-Ching MengNicholas K. TonksDeborah E. Cool
    • C12Q001/42
    • C12Q1/42
    • The invention relates to a method of identifying any protein tyrosine phosphatase (PTP) that undergoes reversible modification of PTP active site invariant cysteine within a cell, such that the phosphatase is transiently protected from irreversible active site invariant cysteine-directed PTP inactivating agents. Methods related to regulation of PTPs by reactive oxygen species (ROS) in a cellular environment are provided. Multiple PTPs are shown to be reversibly oxidized and inactivated following treatment of cells with H2O2 or with physiological stimuli that promote ROS formation, and inhibition of PTP function is shown to contribute to ROS-induced mitogenesis. Transient oxidation of the PTP catalytic site invariant cysteine is exploited in methods to identify which of multiple candidate PTPs are components of a given biological signal transduction pathway, without a requirement for first specifically purifying any particular candidate PTP.
    • 本发明涉及一种鉴定在细胞内进行PTP活性位点不变半胱氨酸的可逆修饰的任何蛋白质酪氨酸磷酸酶(PTP)的方法,使得磷酸酶被不可逆活性位点不变半胱氨酸指导的PTP灭活剂瞬时保护。 提供了与细胞环境中活性氧(ROS)调节PTP有关的方法。 在用H 2 O 2处理细胞后,或者促进ROS形成的生理刺激,多个PTP被显示为可逆的氧化和灭活,并且显示PTP功能的抑制有助于ROS诱导的有丝分裂。 PTP催化位点不变半胱氨酸的瞬时氧化被用于鉴定多种候选PTP中的哪一种是给定生物信号转导途径的组分的方法,而不需要首先特异性纯化任何特定的候选PTP。